SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)

3 Months Ended

Jul. 02, 2016

Segment Reporting [Abstract]

Selected Information by Business Segment

Selected information by business segment is presented below:

	Three Months Ended
(In thousands)	July 2, 2016			June 27, 2015
Net revenues
Japan	$	14,566		$	17,595
EMEA	45,741			48,811
North America Plasma	73,475			64,443
All Other	78,020			80,219
Net revenues (constant currency)	211,802			211,068
Effect of exchange rates	(1,846		)	2,345
Net revenues (reported)	$	209,956		$	213,413

	Three Months Ended
(In thousands)	July 2, 2016			June 27, 2015
Segment operating income
Japan	$	6,121		$	7,682
EMEA	10,048			10,526
North America Plasma	27,277			26,156
All Other	25,636			28,635
Segment operating income (constant currency)	69,082			72,999
Corporate operating expenses (constant currency)	(48,451		)	(49,252		)
Non-GAAP operating income (constant currency)	20,631			23,747
Effect of exchange rates	(1,306		)	2,080
Non-GAAP operating income (reported)	19,325			25,827
Unallocated amounts
Restructuring and restructuring related costs	18,816			14,816
Deal amortization	7,075			7,405
Asset impairments	1,315			—
Operating (loss) income	$	(7,881	)	$	3,606

Schedule of Revenues by Product Line and Geographic Regions

Net revenues by franchise are as follows:

	Three Months Ended
(In thousands)	July 2, 2016		June 27, 2015		% Increase/ (Decrease)
Plasma	$	97,649	$	88,527	10.3	%
Blood Center	70,943		83,083		(14.6	)%
Cell Processing	26,076		27,813		(6.2	)%
Hemostasis Management	15,288		13,990		9.3	%
Net revenues	$	209,956	$	213,413	(1.6	)%

Net revenues generated in our principle operating regions on a reported basis are as follows:

	Three Months Ended
	July 2, 2016		June 27, 2015
United States	$	125,700	$	120,695
Japan	14,964		14,734
Europe	40,367		50,288
Asia	26,992		25,520
Other	1,933		2,176
Net revenues	$	209,956	$	213,413